MYX 5.14% $7.37 mayne pharma group limited

If Nextstellis were to gain traction as a preferable oral...

  1. 1,340 Posts.
    lightbulb Created with Sketch. 251
    If Nextstellis were to gain traction as a preferable oral contraceptive and pray it does , taking into account our money spent taking on taking on a newly developed product Nextstellis the risk was all ours , the massive amount of money spent marketing / establishing a product we don't even own . Who knows if product will succeed to get a decent market oral contraceptive share in the States or using oral contraceptives becomes a thing of the past only time will tell , but considering its our money that's gone into this contraceptive to try to get decent market share in the States surely it makes sense if it were possible to own something that as of now we only the rights to sell and money spent getting this product off the ground we might as well own it . Obviously it comes down to cost and affordability provided the opportunity arises of course .
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$7.37
Change
0.360(5.14%)
Mkt cap ! $626.9M
Open High Low Value Volume
$7.01 $7.46 $6.99 $2.670M 366.2K

Buyers (Bids)

No. Vol. Price($)
1 2000 $7.32
 

Sellers (Offers)

Price($) Vol. No.
$7.39 959 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$7.34
  Change
0.360 ( 4.83 %)
Open High Low Volume
$7.00 $7.47 $7.00 48349
Last updated 15.59pm 03/05/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.